
Sign up to save your podcasts
Or


Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
By Adam Graham4.7
3939 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].

1,962 Listeners

192 Listeners

514 Listeners

338 Listeners

267 Listeners

1,064 Listeners

417 Listeners

42 Listeners

259 Listeners

942 Listeners

41 Listeners

450 Listeners

13 Listeners

719 Listeners

371 Listeners

409 Listeners

42 Listeners

39 Listeners

14 Listeners

19 Listeners

5 Listeners

6 Listeners

25 Listeners

30 Listeners

9 Listeners

243 Listeners

9 Listeners

203 Listeners

5 Listeners

17 Listeners

38 Listeners

4 Listeners

4 Listeners